Two of the three offerings bring AI-assisted productivity to .NET and cross-platform app developers. Highlights include AI ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...